National Partnership Agreement on Essential Vaccines Performance Reports
These reports assess the performance of State and Territory governments against the four benchmarks associated with reward payments in the National Partnership Agreement on Essential Vaccines (NP). The four benchmarks are:
- Benchmark 1: maintaining or increasing vaccine coverage for Indigenous Australians
- Benchmark 2: maintaining or increasing coverage in agreed areas of low immunisation coverage
- Benchmark 3: maintaining or decreasing wastage and leakage
- Benchmark 4: maintaining or increasing vaccination coverage for four year olds.
The Productivity Commission's role is to provide an independent assessment to the Council of Australian Governments (COAG) on whether States and Territories have achieved the performance benchmarks in the NP.
The assessment is provided to COAG before reward payments are made. The Productivity Commission does not recommend whether payments should be made under the NP.

National Partnership Agreement on Essential Vaccines 2016-2017
This report assesses the performance of State and Territory government against the four benchmarks set out in the National Partnership Agreement on Essential Vaccines for the period 1 April 2016 to 31 March 2017.

National Partnership Agreement on Essential Vaccines 2015-2016
This report assesses the performance of State and Territory government against the four benchmarks set out in the National Partnership Agreement on Essential Vaccines for the period 1 April 2015 to 31 March 2016.

National Partnership Agreement on Essential Vaccines 2014-2015
This report assesses the performance of State and Territory government against the four benchmarks set out in the National Partnership Agreement on Essential Vaccines for the period 1 April 2014 to 31 March 2015.

National Partnership Agreement on Essential Vaccines 2013-2014
This report assesses the performance of State and Territory government against the four benchmarks set out in the National Partnership Agreement on Essential Vaccines for the period 1 April 2013 to 31 March 2014.